Early Radiation Oncology Involvement Alongside Standard Oncologic Care for Radiation Therapy

Phase-Based Progress Estimates
RWJBarnabas Health - Community Medical Center, Toms River, NJ
Radiation Therapy+2 More
Early Radiation Oncology Involvement Alongside Standard Oncologic Care - CombinationProduct
All Sexes
What conditions do you have?

Study Summary

To determine if the experimental approach of early radiation oncology involvement alongside standard oncologic care will result in higher HRQL at 6 months compared to the control arm receiving standard oncologic care alone, based on the global subscale score of the European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 questionnaire.

Eligible Conditions

  • Radiation Therapy
  • Metastatic Cancers

Treatment Effectiveness

Effectiveness Progress

2 of 3
This is further along than 85% of similar trials

Study Objectives

1 Primary · 2 Secondary · Reporting Duration: 12 months

12 Months
Levels of HRQL
12 months
EORTC Core Quality of Life questionnaire (EORTC QLQ-C30)
Health Index Score
Vertical Visual Analogue Scale (EQ visual analogue scale)
At Six Months
Measure of Health-related quality of life (HRQL) at six months

Trial Safety

Safety Progress

3 of 3
This is further along than 85% of similar trials

Trial Design

2 Treatment Groups

Arm 1
1 of 2
Arm 2
1 of 2
Experimental Treatment

156 Total Participants · 2 Treatment Groups

Primary Treatment: Early Radiation Oncology Involvement Alongside Standard Oncologic Care · No Placebo Group · Phase 3

Arm 1
Experimental Group · 1 Intervention: Questionnaires · Intervention Types: Other
Arm 2
Experimental Group · 1 Intervention: Early Radiation Oncology Involvement Alongside Standard Oncologic Care · Intervention Types: CombinationProduct

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 12 months
Closest Location: RWJBarnabas Health - Community Medical Center · Toms River, NJ
Photo of new jersey 1Photo of new jersey 2Photo of new jersey 3
N/AFirst Recorded Clinical Trial
1 TrialsResearching Radiation Therapy
0 CompletedClinical Trials

Who is running the clinical trial?

Rutgers, The State University of New JerseyLead Sponsor
361 Previous Clinical Trials
60,031 Total Patients Enrolled
1 Trials studying Radiation Therapy
30 Patients Enrolled for Radiation Therapy
Malcolm Mattes, MDPrincipal InvestigatorRutgers Cancer Institute of New Jersey
2 Previous Clinical Trials
4 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 8 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You have cancer, with primary site outside of the central nervous system.
You have metastatic disease for which curative intent treatment is not feasible and treatment goals are palliative.
You are able to understand the information you are being asked to provide and you are willing to sign a written informed consent document.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.